JV001

N/A

Report date: 2024/12/20 14:32:59

Base Information

Drug NameJV001
Drug Alias NameJV001JV-001
ClassificationBiologics
Mechanisms of ActionTelomerase reverse transcriptase activators
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsHeart FailureCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Juvensis Therapeutics Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Juvensis Therapeutics Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHeart FailureCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A